Clinical trials: Penile Enhancement
Penile Girth Enhancement
HYAcorp MLF1 Hyaluronic Acid Filler for Penile Girth Enhancement
The goal of this clinical trial is to learn how well HYAcorp MLF1, a hyaluronic acid filler, works for penile girth enhancement in men aged 25 years or older.
- Trial name
- NCT07877077
- Testing
- cross-linked hyaluronic acid
- Where
- Turkey (Türkiye)
- Volunteers
- 65 people
- Sponsor
- Biruni University
Bone Cancer, Brain Cancer
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
This is a prospective single-arm study of an enhanced assistance intervention for patients with unmet essential needs undergoing >10 fractions of radiotherapy comparing delay-free completion of radiotherapy in study participants…
- Conditions
- Bone Cancer, Brain Cancer, Colorectal Cancer, Esophagus Cancer
- Trial name
- EARN (NCT06582849)
- Testing
- Standard assistance, Enhanced assistance
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Washington University School of Medicine
Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence of Non-organic Origin
Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy
The purpose of this study is to evaluate whether using penile vibratory stimulation with the Viberect handheld device can help the recovery of erections and urinary control after radical prostatectomy.
- Trial name
- NCT01718704
- Testing
- Viberect device
- Where
- 2 sites in United States
- Sponsor
- Johns Hopkins University
Penile Girth Enhancement, Penile Enhancement
The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement
This clinical study is for small-penis syndrome males who have previously been treated with hyaluronic acid filler for the purpose of increasing their penis.
- Trial name
- NCT03840070
- Testing
- Potenfill
- Where
- South Korea
- Volunteers
- 20 people
- Sponsor
- Medy-Tox
Micropenis
Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement
Injectable filler will be performed by Principal Investigator under sterile conditions for the enhancement of girth and surface area of the penis.
- Trial name
- NCT04755634
- Testing
- Hyaluronic Acid
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Shafer Clinic Fifth Avenue
Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN
Avelumab With Valproic Acid in Virus-associated Cancer
Up to 20% of all cancers may be associated with a bacterial or viral infection. In some instances, the infection may be one of the reasons why the cancer developed in the first place.
- Conditions
- Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN, Squamous Cell Carcinoma of the Cervix, p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva
- Trial name
- LATENT (NCT03357757)
- Testing
- Valproic Acid, Avelumab
- Where
- Canada
- Volunteers
- 39 people
- Sponsor
- AHS Cancer Control Alberta
Penile Enhancement
Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
This is an observational study to determine the efficacy and safety of Potenfill for temporary penile enhancement. The pivotal study of Potenfill has already been completed and this observational study determines the long-term…
- Trial name
- NCT04496427
- Where
- South Korea
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- Medy-Tox
Distal Hypospadias, Hypospadias
Fibrin-Enhanced TIP Versus Grafted TIP Urethroplasty in Distal Hypospadias
Hypospadias is a common congenital condition in boys in which the opening of the urethra is located on the underside of the penis.
- Trial name
- FTIP-RCT (NCT07319780)
- Testing
- Fibrin-Enhanced TIP Urethroplasty, Grafted TIP Urethroplasty
- Where
- 2 sites in Indonesia, Uzbekistan
- Volunteers
- 100 people
- Sponsor
- National Children's Medical Center, Uzbekistan
Penile Enhancement
Efficacy and Safety of Potenfill for Temporary Penile Enhancement
The purpose of this study is to evlauate the efficacy and safety of poteinfill, compared to the powerfill.
- Trial name
- NCT03512717
- Testing
- Potenfill, Powerfill
- Where
- South Korea
- Volunteers
- 76 people, healthy volunteers welcome
- Sponsor
- Medy-Tox
Penile Enhancement
A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement
The purpose of this study is to evaluate non-inferial study of the after using Volus application, compared to the powerfill.
- Trial name
- NCT02833532
- Testing
- Volus/Powerfill
- Where
- South Korea
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Hugel
Adult Solid Tumor
Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
This is a Phase 1/2, first-in-human, open label, multicenter study to assess safety and tolerability, antitumor activity, and immunogenic and pharmacodynamic effects of SQZ-eAPC-HPV as monotherapy and in combination with…
- Trial name
- NCT05357898
- Testing
- SQZ-eAPC-HPV, Pembrolizumab
- Where
- 9 sites in United States
- Volunteers
- 20 people
- Sponsor
- SQZ Biotechnologies
Penile Girth Augmentation, Fat Graft
Efficacy and Stability of Autologous Fat Grafting for Penile Girth Augmentation
The primary aim of this study is to evaluate the clinical and radiological efficacy and long-term stability of autologous fat grafting as a method for girth augmentation.
- Trial name
- NCT07547839
- Testing
- Autologous Fat Grafting
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Assiut University
Small Penis, Penile Enhancement
Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement
The investigators aimed to confirm the efficacy and safety of transdermal penis enlargement for 24 weeks after CMDHA0101 injection in subjects who wanted penile enlargement in male patients with small-penis syndrome *.
- Trial name
- NCT03153735
- Testing
- CMDHA0101, PowerFill®
- Where
- South Korea
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- CHA MEDITECH Co., Ltd.